Search

everythinglearnresearchcommunity

for

Search:↓

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Managing recurrent painless thyroiditis is challenging and should be personalized based on episode frequency, severity, symptoms, and patient preferences.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

TAK-279 effectively reduces psoriasis symptoms and is safe.

CRH causes hair loss by reducing autophagy and increasing cell death in hair cells.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Consider THPP in patients with muscle weakness and low potassium, as it is often underdiagnosed.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Tirzepatide may improve hair loss by reducing insulin resistance.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Targeting the PGD2-DP2 pathway may help treat hair loss.